The transcriptional coactivators p300/CBP have acetyltransferase (AT) activity. Their important functions contribute to cell proliferation and differentiation through the following mechanisms: (1) acetylation of histones, p53 and other transcription factors; and , (2) chromatin modification during transcription. In fact, mutations within the AT domain of p300/CBP genes have been linked to colorectal and gastric and carcinomas, suggesting that aberrant regulation of the AT domain activity may play important roles in cancer. We have demonstrated recently that the adenoviral oncoprotein E1A and INHAT, a novel human cellular complex which contains that Set oncoprotein, regulate p300- mediated histone acetylation, nuclear hormone receptor mediated hormone signaling, and gene transcription (Cell 96, 393, 1999 and Cell 104, 119, 2001). P53 is a common target in most human cancers. Mutations in amino acids that prevent the ability of p53 to bind specific DNA sequences and to activate p53-regulated genes have been implicated in the development of colon, pancreas, stomach, and esophageal cancers. Since p300 acetylation of p53 plays an important role in the ability to bind DNA, we hypothesize that the INHAT complex regulates the biological functions of p53. The following interrelated Specific Aims are proposed: (1) To determine whether the INHAT complex and the oncoprotein Set regulate p53 acetylation and influence its biological function; and (2) To determine the regulation of INHAT subunit expression in digestive tract cancers. Successful completion of the proposed studies will provide insights into novel mechanisms of p53 regulation and may provide therapeutic targets for p53 linked digestive tract cancers.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK050306-06
Application #
6646835
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2002-07-15
Project End
2007-06-30
Budget Start
Budget End
Support Year
6
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Wang, Amber W; Wangensteen, Kirk J; Wang, Yue J et al. (2018) TRAP-seq identifies cystine/glutamate antiporter as a driver of recovery from liver injury. J Clin Invest 128:2297-2309
Lang, Fengchao; Sun, Zhiguo; Pei, Yonggang et al. (2018) Shugoshin 1 is dislocated by KSHV-encoded LANA inducing aneuploidy. PLoS Pathog 14:e1007253
Giroux, Véronique; Stephan, Julien; Chatterji, Priya et al. (2018) Mouse Intestinal Krt15+ Crypt Cells Are Radio-Resistant and Tumor Initiating. Stem Cell Reports 10:1947-1958
Barnoud, Thibaut; Budina-Kolomets, Anna; Basu, Subhasree et al. (2018) Tailoring Chemotherapy for the African-Centric S47 Variant of TP53. Cancer Res 78:5694-5705
Wangensteen, Kirk J; Wang, Yue J; Dou, Zhixun et al. (2018) Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform. Hepatology 68:663-676
Andres, Sarah F; Williams, Kathy N; Rustgi, Anil K (2018) The Molecular Basis of Metastatic Colorectal Cancer. Curr Colorectal Cancer Rep 14:69-79
Serper, M; Forde, K A; Kaplan, D E (2018) Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct-acting antiviral therapy for chronic hepatitis C: Data from a national US cohort. J Viral Hepat 25:187-197
Avetisyan, Marina; Rood, Julia E; Huerta Lopez, Silvia et al. (2018) Muscularis macrophage development in the absence of an enteric nervous system. Proc Natl Acad Sci U S A 115:4696-4701
Kim, Yong Hoon; Marhon, Sajid A; Zhang, Yuxiang et al. (2018) Rev-erb? dynamically modulates chromatin looping to control circadian gene transcription. Science 359:1274-1277
Costea, Paul I; Hildebrand, Falk; Arumugam, Manimozhiyan et al. (2018) Enterotypes in the landscape of gut microbial community composition. Nat Microbiol 3:8-16

Showing the most recent 10 out of 700 publications